泪液渗透压与干眼病体征和症状的关联:干眼评估与管理(DREAM)研究
在405例中重度干眼病患者中,基线及6、12个月泪液渗透压均值约303 mOsm/L;泪液渗透压与结膜和角膜染色评分、泪膜破裂时间、Schirmer试验呈弱相关,与眼表疾病指数评分无相关;泪液渗透压变化与体征和症状变化无显著相关。
要点
- 泪液渗透压与结膜染色(r=0.18)和角膜染色(r=0.17)呈弱相关,解释体征变异<5%。
- 泪液渗透压与眼表疾病指数评分无相关(r=0.03;P=0.40)。
- 泪液渗透压变化与6或12个月时体征和症状变化无显著相关。
核心结论
- 泪液渗透压与干眼病体征呈弱相关,解释体征变异<5%;泪液渗透压变化与体征和症状变化无关,提示该关联可能非因果。
研究设计与样本
- 干眼评估与管理(DREAM)研究中405例中重度干眼病患者,在基线及6和12个月评估泪液渗透压与体征和症状的关联,使用Pearson相关系数和回归模型。
主要发现
- 基线泪液渗透压均值(标准差)为303(16)mOsm/L,6和12个月均为303(18)mOsm/L。
- 年龄≥70岁者泪液渗透压为306 mOsm/L,高于<50岁者的300 mOsm/L(P=0.01);干燥病患者为311 mOsm/L,高于无干燥病者的302 mOsm/L(P<0.0001)。
- 随机分配至安慰剂组与omega-3脂肪酸补充剂组的患者泪液渗透压无差异。
- 泪液渗透压与结膜染色评分(r=0.18;P<0.001)、角膜染色评分(r=0.17;P<0.001)、泪膜破裂时间(r=0.06;P=0.03)和Schirmer试验评分(r=-0.07;P=0.02)呈弱相关,与眼表疾病指数评分无相关(r=0.03;P=0.40)。
- 6或12个月时体征和症状变化与泪液渗透压变化无显著相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the relationships of (1) tear osmolarity (TO) levels with the severity of signs and symptoms of dry eye disease (DED) and (2) changes in TO with changes in signs and symptoms. METHODS: Patients (N = 405) with moderate to severe DED in the Dry Eye Assessment and Management (DREAM) Study were evaluated at baseline and at six and 12 months. Associations of TO with signs and symptoms were evaluated using Pearson correlation coefficient (r) and regression models. RESULTS: The mean (standard deviation [SD]) TO was 303 (16) mOsm/L at baseline and 303 (18) mOsm/L at both six and 12 months. TO was higher in older patients (306 mOsm/L for ≥70 years vs. 300 mOsm/L for <50 years; P = 0.01) and those with Sjögren's disease (311 vs. 302 mOsm/L; P < 0.0001). TO did not differ between patients randomized to placebo and omega-3 fatty acid supplementation. TO was weakly correlated with conjunctival (r = 0.18; P < 0.001) and corneal staining scores (r = 0.17; P < 0.001), tear film break-up time (r = 0.06; P = 0.03), and Schirmer test score (r = -0.07; P = 0.02) but not with Ocular Surface Disease Index scores (r = 0.03; P = 0.40). Changes in signs and were not significantly correlated with change in TO at six or 12 months. CONCLUSIONS: Within DREAM, TO was weakly correlated with DED signs, explaining <5% variability in signs. Changes in tear osmolarity were not associated with changes in signs and symptoms of DED, indicating that the association may not be causal.
引用
- Greiner JV, Ying GS, Pistilli M, et al. Association of Tear Osmolarity With Signs and Symptoms of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study. Invest Ophthalmol Vis Sci. 2023. PMID: 36626176. doi:10.1167/iovs.64.1.5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。